ES8705033A1 - Un metodo para preparar una vacuna para uso en el tratamiento prevencion de diarrea porcina neonatol. - Google Patents

Un metodo para preparar una vacuna para uso en el tratamiento prevencion de diarrea porcina neonatol.

Info

Publication number
ES8705033A1
ES8705033A1 ES549531A ES549531A ES8705033A1 ES 8705033 A1 ES8705033 A1 ES 8705033A1 ES 549531 A ES549531 A ES 549531A ES 549531 A ES549531 A ES 549531A ES 8705033 A1 ES8705033 A1 ES 8705033A1
Authority
ES
Spain
Prior art keywords
cloning
dna
vaccine
large fragment
vehicle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES549531A
Other languages
English (en)
Other versions
ES549531A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotech Australia Pty Ltd
Inhibin Pty Ltd
Original Assignee
Biotech Australia Pty Ltd
Biotechnology Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd, Biotechnology Australia Pty Ltd filed Critical Biotech Australia Pty Ltd
Publication of ES8705033A1 publication Critical patent/ES8705033A1/es
Publication of ES549531A0 publication Critical patent/ES549531A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

METODO DE PREPARAR UNA VACUNA PARA USO EN EL TRATAMIENTO O PREVENCION DE DIARREA PORCINA NEONATAL. CONSISTE EN: A) PURIFICAR ANTIGENOS FIMBRICOS DISTINTOS DE 987P; B) CULTIVAR CELULAS HOSPEDANTES RECOMBINANTES DE E. COLI QUE EXPRESAN EL GEN 987P EN UN MEDIO QUE COMPRENDE SALES DE EXTRACTO DE LEVADURA Y TRIPTONA, Y UNA FUENTE DE CARBONO; C) AISLAR EL PRODUCTO FIMBRIAL SEPARANDO DEL CALDO DE CULTIVO LA BIOMASA RESIDUAL POR CENTRIFUGACION Y LAVANDO LA SUSPENSION DE FIMBRIAS CON SOLUCIONES TAMPON; D) AÑADIR LA PROTEINA FIMBRICA 987P, RESULTANTE DE LA OPERACION C), A LOS ANTIGENOS FIMBRICOS PURIFICADOS DISTINTOS DE 987P; Y E) AÑADIR AL MATERIAL RESULTANTE UN VEHICULO, DILUYENTE O COADYUVANTE. TIENE APLICACIONES EN EL CAMPO DE LA INVESTIGACION VETERINARIA.
ES549531A 1984-12-04 1985-12-03 Un metodo para preparar una vacuna para uso en el tratamiento prevencion de diarrea porcina neonatol. Expired ES8705033A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPG840384 1984-12-04

Publications (2)

Publication Number Publication Date
ES8705033A1 true ES8705033A1 (es) 1987-04-16
ES549531A0 ES549531A0 (es) 1987-04-16

Family

ID=3770864

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549531A Expired ES8705033A1 (es) 1984-12-04 1985-12-03 Un metodo para preparar una vacuna para uso en el tratamiento prevencion de diarrea porcina neonatol.

Country Status (14)

Country Link
EP (1) EP0242359B1 (es)
JP (1) JPS62501675A (es)
KR (1) KR870700021A (es)
CN (1) CN1017451B (es)
AU (1) AU596958B2 (es)
DE (1) DE3587473T2 (es)
DK (1) DK370186A (es)
ES (1) ES8705033A1 (es)
FI (1) FI863145A (es)
HK (1) HK70594A (es)
NZ (1) NZ214428A (es)
SG (1) SG87794G (es)
WO (1) WO1986003410A1 (es)
ZA (1) ZA859297B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU616662B2 (en) * 1987-04-27 1991-11-07 Commonwealth Scientific And Industrial Research Organisation Peptide production by protein engineering
EP0314224B1 (en) * 1987-10-26 1992-05-27 Akzo N.V. Vaccine against e.coli septicaemia in poultry
HU221664B1 (hu) * 1999-03-31 2002-12-28 MTA Állatorvostudományi Kutatóintézete Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás
CN107693786B (zh) * 2017-11-07 2021-06-29 聊城大学 特异性防治驴驹大肠杆菌性腹泻的复合疫苗

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2094314A (en) * 1981-02-05 1982-09-15 Wellcome Found Recombinant DNA
NZ199866A (en) * 1981-03-09 1984-11-09 Cetus Corp Vaccine for prevention of gastroenteric disease:non-pathogenic strain genetically engineered to comprise genes for adhesin and/or toxoids
DK242883A (da) * 1982-06-02 1983-12-03 Cetus Corp Fremgangsmaade til frembringelse af konstruerede rekombinant plasmider
DK410783D0 (da) * 1982-09-16 1983-09-09 Benzon A Salfred Fremgangsmade til stabilisering af plasmider
JPH074257B2 (ja) * 1983-06-17 1995-01-25 三菱油化株式会社 新規なプラスミド
EP0180192B1 (en) * 1984-10-29 1992-02-05 Research Association For Utilization Of Light Oil Novel plasmids
JPH0694095A (ja) * 1992-09-08 1994-04-05 Mitsubishi Steel Mfg Co Ltd 回転抵抗調整機構

Also Published As

Publication number Publication date
ZA859297B (en) 1986-08-27
CN85109506A (zh) 1986-09-10
EP0242359A4 (en) 1989-02-23
DE3587473D1 (es) 1993-08-26
JPS62501675A (ja) 1987-07-09
FI863145A0 (fi) 1986-08-01
DE3587473T2 (de) 1993-11-04
SG87794G (en) 1994-10-14
EP0242359B1 (en) 1993-07-21
KR870700021A (ko) 1987-02-28
FI863145A (fi) 1986-08-01
NZ214428A (en) 1989-04-26
AU5209786A (en) 1986-07-01
EP0242359A1 (en) 1987-10-28
CN1017451B (zh) 1992-07-15
DK370186A (da) 1987-03-20
HK70594A (en) 1994-07-29
DK370186D0 (da) 1986-08-04
WO1986003410A1 (en) 1986-06-19
ES549531A0 (es) 1987-04-16
AU596958B2 (en) 1990-05-24

Similar Documents

Publication Publication Date Title
Yates et al. E. coli ribosomal protein L4 is a feedback regulatory protein
EG19101A (en) Process for preparing of expression of human proapolipoprotein A.1.
AU8783991A (en) Polypeptide,dna fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
GR3034349T3 (en) Neutralizing monoclonal antibodies to respiratory syncytial virus
FI920923A0 (fi) Fusionsproteiner, deras framstaellning samt anvaendning.
IL77227A (en) Recombinant methods for production of serine protease inhibitors and methods for isolation of same
DK0562508T3 (da) Nyt knogle-relateret protein OSF-2, fremgangsmåde til dets fremstilling samt farmaceutisk præparat med indhold deraf
ES8705033A1 (es) Un metodo para preparar una vacuna para uso en el tratamiento prevencion de diarrea porcina neonatol.
AU2795989A (en) Production of gonorrheal pi proteins and vaccines
AU551490B2 (en) Dna code for protein to suppress abnormal protein degradation
SE8101665L (sv) Polypeptidframstellning
EP0048455A3 (en) Synthetic dna and process therefor
AU3475495A (en) Process for producing recombinant proteins, plasmids and modified cells
EP0145486A3 (en) Microbiological process
AU1439388A (en) High titer production of human somatomedin c
ES554327A0 (es) Un procedimiento para preparar un plasmido recombinante
EP0295285B1 (en) Method for the production of bovine growth hormone using a synthetic gene
TH4039A (th) ขบวนการผลิตและวัคซีน
IE894177L (en) Plasmids with a translation start-stop-start codon¹configuration for the expression of proteins in E. coli
SE8505568L (sv) Expressionvektor och forfarande for framstellning derav
EP0195087A4 (en) CYCLIC DOUBLE-STRANDED DNA, THEIR POSITION, MICRO-ORGANISMS CONTAINING THEM, METHOD FOR THE PRODUCTION OF AN ANTI-DETERMINANT LOCATION OF THE POLIOVIRUS CAPSIDE AND PROTEIN-VP1, USED THEREOF.
Yudelevich Modification of Leucine tRNA of Escherichia coli After Bacteriophage T4 Infection
JPS6474988A (en) Synthetic gene of cystatin c, corresponding recombinant plasmid and recombinant
ES8800984A1 (es) Un metodo para obtener adn que codifica factor de necrosis de tumores mutante

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971103